Loading…
Loading…
where do we go from here on the margin front? How big a driver of your operating margin goals is gross margin?
is this still the ASC a net positive given maybe potentially lower WATCHMAN implants
How do we think about this, is renal innovation here now, given the recent approvals?
maybe talk if you would about not tariffs specifically, but sort of other aspects of the trade wars